<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Sanara Medtech Inc — News on 6ix</title>
<link>https://6ix.com/company/sanara-medtech-inc</link>
<description>Latest news and press releases for Sanara Medtech Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 14 Apr 2026 04:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/sanara-medtech-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c1c978dffbe2df1190e3.webp</url>
<title>Sanara Medtech Inc</title>
<link>https://6ix.com/company/sanara-medtech-inc</link>
</image>
<item>
<title>Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-to-report-first-quarter-2026-financial-results-on-may-12-2026</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-to-report-first-quarter-2026-financial-results-on-may-12-2026</guid>
<pubDate>Tue, 14 Apr 2026 04:00:00 GMT</pubDate>
<description>FORT WORTH, TX, April 14, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company”, “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology</description>
</item>
<item>
<title>Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-fourth-quarter-unaudited-and-full-year-2025-financial-results-reaffirmed-full-year-2026-financial-guidance</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-fourth-quarter-unaudited-and-full-year-2025-financial-results-reaffirmed-full-year-2026-financial-guidance</guid>
<pubDate>Tue, 24 Mar 2026 04:00:00 GMT</pubDate>
<description>FORT WORTH, TX, March 24, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology</description>
</item>
<item>
<title>Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-publication-of-peer-reviewed-study-evaluating-the-economic-and-clinical-value-of-celleraterxr-surgical-powder-in-the-management-of-spine-surgery-wounds</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-publication-of-peer-reviewed-study-evaluating-the-economic-and-clinical-value-of-celleraterxr-surgical-powder-in-the-management-of-spine-surgery-wounds</guid>
<pubDate>Wed, 11 Mar 2026 04:00:00 GMT</pubDate>
<description>Study demonstrates cost savings and improved health outcomes associated with the use of CellerateRX® as an adjunct to the standard of care for high-risk</description>
</item>
<item>
<title>Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-24-2026</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-24-2026</guid>
<pubDate>Tue, 03 Mar 2026 12:30:00 GMT</pubDate>
<description>FORT WORTH, TX, March 03, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that it will report its fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026 before the U.S. financial markets open. The Company will hos</description>
</item>
<item>
<title>Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-participate-td-123000846</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-participate-td-123000846</guid>
<pubDate>Tue, 17 Feb 2026 12:30:00 GMT</pubDate>
<description>FORT WORTH, TX, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that management will participate in the TD Cowen 46th Annual Health Care Conference, which is being held at the Boston Marriott Copley Place in Boston, MA from Marc</description>
</item>
<item>
<title>Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-unaudited-123000020</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-unaudited-123000020</guid>
<pubDate>Fri, 23 Jan 2026 12:30:00 GMT</pubDate>
<description>FORT WORTH, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara MedTech,” “Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported certain unaudited preliminary financial results for the fourth quarter and full year ended December 31, 2025, and introduced its financial guidance</description>
</item>
<item>
<title>Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-receives-innovative-210500479</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-receives-innovative-210500479</guid>
<pubDate>Wed, 07 Jan 2026 21:05:00 GMT</pubDate>
<description>Contract awarded for products that bring improvement to the healthcare industry FORT WORTH, TX, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara MedTech,” “Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today announced that its BIASURGE® Advanced Surgical Solution (“BIASURGE”) product</description>
</item>
<item>
<title>Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-biomimetic-innovations-133700248</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-biomimetic-innovations-133700248</guid>
<pubDate>Wed, 10 Dec 2025 13:37:00 GMT</pubDate>
<description>Poised for U.S. market launch in Q1 2027 following the achievement of recent milestones and OsStic’s granted patent in 2025 FORT WORTH, TX, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, together with Biomimetic Innovations Ltd (“BMI”), today</description>
</item>
<item>
<title>Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-participate-piper-sandler-123000015</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-participate-piper-sandler-123000015</guid>
<pubDate>Wed, 19 Nov 2025 12:30:00 GMT</pubDate>
<description>FORT WORTH, TX, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that management will participate in the Piper Sandler 37th Annual Healthcare Conference, which is being held at The Lotte New York Palace in New York, NY from Decem</description>
</item>
<item>
<title>Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited)</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-third-120000776</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-third-120000776</guid>
<pubDate>Wed, 12 Nov 2025 12:00:00 GMT</pubDate>
<description>Net Revenue Increased 22% Year-Over-Year in Q3; Increased 25% Year-Over-Year in First Nine Months of 2025 FORT WORTH, TX, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, today reported its financial results for the third quarter ended September</description>
</item>
<item>
<title>Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-strategic-210500173</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-strategic-210500173</guid>
<pubDate>Tue, 11 Nov 2025 21:05:00 GMT</pubDate>
<description>Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market, announced today that the Company completed its previously announced evaluation of strategic alternativ</description>
</item>
<item>
<title>Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-report-third-quarter-113000551</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-report-third-quarter-113000551</guid>
<pubDate>Wed, 01 Oct 2025 11:30:00 GMT</pubDate>
<description>FORT WORTH, TX, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, today announced it will report its third quarter 2025 financial results on Wednesday, November 12, 2025 before the U.S. financial markets open. The Company will host a confe</description>
</item>
<item>
<title>Sanara MedTech Inc. Announces Chief Executive Officer Transition</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-chief-203000138</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-chief-203000138</guid>
<pubDate>Tue, 02 Sep 2025 20:30:00 GMT</pubDate>
<description>Seth Yon Appointed President, Chief Executive Officer and Director; Ron Nixon to Remain Executive Chairman FORT WORTH, TX, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, today announced that Seth Yon, Sanara’s Preside</description>
</item>
<item>
<title>Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-present-cantor-200500468</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-present-cantor-200500468</guid>
<pubDate>Wed, 27 Aug 2025 20:05:00 GMT</pubDate>
<description>FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, today announced that management will present at the Cantor Global Healthcare Conference, which is being held at the New York Marriott Marquis in New York,</description>
</item>
<item>
<title>Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-second-110000253</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-second-110000253</guid>
<pubDate>Wed, 13 Aug 2025 11:00:00 GMT</pubDate>
<description>Net Revenue Increased 28% Year-Over-Year in Q2; Increased 27% Year-Over-Year in First Six Months of 2025 Announces Process to Evaluate Strategic Alternatives for its Tissue Health Plus, LLC Subsidiary FORT WORTH, TX, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in</description>
</item>
<item>
<title>Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-report-second-quarter-200500129</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-report-second-quarter-200500129</guid>
<pubDate>Tue, 15 Jul 2025 20:05:00 GMT</pubDate>
<description>FORT WORTH, TX, July 15, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, today announced it will report its second quarter 2025 financial results on Wednesday, August 13, 2025 before the U.S. financial markets open. The Company will host a confer</description>
</item>
<item>
<title>Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-launch-200500431</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-announces-launch-200500431</guid>
<pubDate>Mon, 14 Jul 2025 20:05:00 GMT</pubDate>
<description>Pilot program designed to provide real-world evidence in the use of Tissue Health Plus’ technology platform FORT WORTH, TX, July 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skin markets, today announced the recent launch, through its</description>
</item>
<item>
<title>Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-first-110000545</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-inc-reports-first-110000545</guid>
<pubDate>Wed, 14 May 2025 11:00:00 GMT</pubDate>
<description>Q1 Net Revenue Increased 26% Year-Over-Year FORT WORTH, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financia</description>
</item>
<item>
<title>Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-report-first-quarter-120000604</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-report-first-quarter-120000604</guid>
<pubDate>Wed, 23 Apr 2025 12:00:00 GMT</pubDate>
<description>FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced it will report its first quarter 2025 financial results on Wednesday, May 14, 2025 before the U.S. financial markets open. The Company will host a confe</description>
</item>
<item>
<title>Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025</title>
<link>https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-present-planet-microcap-200000827</link>
<guid isPermaLink="true">https://6ix.com/company/sanara-medtech-inc/news/sanara-medtech-present-planet-microcap-200000827</guid>
<pubDate>Thu, 10 Apr 2025 20:00:00 GMT</pubDate>
<description>FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that management will present at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, which is being held at the</description>
</item>
</channel>
</rss>